Hypertension has been long recognized as one of the major risk factors for cardiovascular disease and premature deaths worldwide. It is estimated to cause 9.4 million deaths and 7.0% of DALYs . In India, it exerts substantial public health burden on Cardiovascular health status and the health care system. It is estimated to account for 10.8% of all the deaths and 4.6% of DALYs in the country. The adult Hypertension prevalence has shown a drastic increase in the past three decades in urban as well as rural areas. It is estimated that 16% of Ischaemic Heart Disease, 21% of Peripheral Vascular Disease, 24% of Acute Myocardial Infarctions and 29% of strokes are attributed to hypertension. This stresses the need for its effective management and control and it highlights the huge impact it can have on the burden of Cardiovascular Diseases.
The increasing burden of Hypertension necessitates key strategies and policies for its prevention and effective management. There are several issues that arise when it comes to management of hypertension such as lack of availability of doctors (very low doctor to population ratio), concentration of specialists in urban areas and lack of training in management of hypertension at the graduate level (MBBS)
In the backdrop of these issues, Public Health Foundation of India, Centre for Chronic Disease Control, International Society of Hypertension and British Hypertension Society have started this Capacity Building initiative in Hypertension Management for primary care physicians in India.
The CCMH is a joint certification Program by Public Health Foundation of India (PHFI), New Delhi, Centre for Chronic Disease Control (CCDC), New Delhi, International Society of Hypertension (ISH) and British & Irish Hypertension Society (BIHS). The program is supported by an educational grant from Sun Pharma laboratories Limited.
The Public Health Foundation of India (PHFI) is a public private initiative that has collaboratively evolved through consultations with multiple constituencies including Indian and International academia, state and central governments, multi & bi-lateral agencies and civil society groups. PHFI is a response to redress the limited institutional capacity in India for strengthening training, research and policy development in the area of Public Health. Structured as an independent foundation, PHFI adopts a broad, integrated approach to public health, tailoring its endeavors to Indian conditions and bearing relevance to the countries facing similar challenges and concerns. The PHFI focuses on broad dimensions of public health that encompass promotive, preventive and therapeutic services, many of which are frequently lost in policy planning as well as in popular understanding. 14th Prime Minister of India launched launched PHFI on March 28, 2006 at New Delhi with a vision to strengthen India's public health institutional and systems capability and provide knowledge to achieve better health outcomes for all. PHFI recognizes the fact that meeting the shortfall of health professionals is imperative to a sustained and holistic response to the public health concerns in the country which in turn requires health care to be addressed not only from the scientific perspective of what works, but also from the social perspective of, who needs it the most.
Centre for Chronic Disease Control (CCDC) is a New Delhi based not-for-profit organization, established in December 2000. The mission of CCDC is primarily intended to address the growing challenge of chronic diseases, in varied settings of the developing countries through, Knowledge generation, which can inform policies and empower programmes for the prevention and control of chronic diseases, and Knowledge translation intended to operationalize research results by bridging the critical gaps between relevant research and effective implementation, through analytic work, capacity building, advocacy and development of educational resources for enhancing the empowerment of people and professionals. CCDC has been recognized as a Scientific and Industrial Research Organization (SIRO) by Department of Scientific & Industrial Research (DSIR), Ministry of Science and Technology, Government of India. It also holds registration under Foreign Contribution (Regulation) Act, 1976. CCDC undertakes clinical research with special emphasis on chronic non-communicable diseases (NCD). Within the spectrum of chronic diseases, our main focus areas are: cardiology, diabetes and metabolic disease, vascular diseases, cancers and mental health. In addition, basic science research in diet/nutrition and cardiac biochemistry are also carried out. The research work at CCDC has produced major insights into the epidemiology, developmental origin, and biomarkers of CVD and diabetes in India; practice patterns on Acute Coronary Syndrome; translation research in CVDs; and development of low-cost combination drugs for primary and secondary prevention of CVDs in South Asia. CCDC holds recognition as a ‘Centre of Excellence in Clinical Research’ from the Clinical Development Service Agency (CDSA), Department of Biotechnology, Government of India. It is also a WHO Collaborating Centre for Surveillance, Capacity building and Translational Research in Cardio-Metabolic Diseases.
Established in 1966, the International Society of Hypertension (ISH) is committed to promoting and encouraging the advancement of scientific research and knowledge and its application to the prevention and management of heart disease and stroke in hypertension and related cardiovascular diseases around the world. The Society was registered as a charity in England and Wales in December 2007. The two key aspirations of the International Society of Hypertension are to support younger members and reach out to as many countries globally as possible. A special focus is given by the ISH through its Regional Advisory Groups to teaching activities in economically disadvantaged countries in Asia, Africa, Eastern Europe and Latin America.
The British Hypertension Society was founded in 1981 by eight clinicians “to provide a suitable forum where physicians, surgeons, physiologists, pharmacologists and others interested in the subject of hypertension could meet and present their work”. In 2016 the membership voted to change the Society’s name to the British & Irish Hypertension Society (BIHS) as it is now known. The British and Irish Hypertension Society is the forum for professionals working in the field of hypertension and cardiovascular disease in the UK and Ireland. The Society comprises doctors, nurses and other healthcare workers specializing in the delivery of care in hypertension and allied fields, together with clinicians and scientists in the forefront of cardiovascular research. The Society provides a broad spectrum of scientific and educational activities. These include the production and regular updating of internationally renowned guidelines for the management of hypertension; an Information Service for healthcare professionals; a Validation Service for manufacturers of blood pressure monitors; coordinating collaborative research into aspects of hypertension and cardiovascular risk; and holding scientific meetings covering all aspects of research and the delivery of care related to hypertension and cardiovascular disease.